NanoVibronix introduces new ultrasound pain management device

The new device expands the company’s portfolio of pain management devices. Credit: Praisaeng / Shutterstock.

Medical device firm NanoVibronix has launched a new ultrasound pain management device, dubbed PainShield Plus, for the treatment of multiple areas of pain in tandem.

Free Report

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.

By GlobalData

By clicking the Download Free Report button, you accept the terms and conditions and acknowledge that your data will be used as described in the GlobalData privacy policy

By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The new device expands the company’s portfolio of pain management devices that includes UroShield, PainShield, and WoundShield Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices.

In addition to a reusable driver unit, it features a second adhesive patch and transducer, which effectively increases the surface area that can be treated for pain in the same duration.

Each transducer covers approximately 20cm of surface area and has two points of access, enabling the bilateral treatment of orthopaedic pain, using a single device.

NanoVibronix CEO Brian Murphy said: “The introduction of PainShield Plus is a natural extension of our highly effective PainShield device. Increasingly, patients are seeking therapies that work synergistically with more conventional treatment plans and reduce the need for pharmaceuticals and surgical interventions.

“We have extended the functionality of our core PainShield device to include an additional transducer that enables patients to cover twice the surface area for pain treatment and thereby broadens the opportunities for application of this proven technology.”

Similar to the company’s previous device, PainShield Plus leverages ultrasound therapy to treat pain and different soft tissue injuries either directly over joints or orthopaedic hardware.

Moreover, this device eliminates the need for opioid treatments. It will also help to maintain social distancing by enabling patients to receive therapy in their own homes safely.

Other patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.